Safety Alerts & Recalls
What does this mean?
The FDA has notified healthcare professionals today about reports of suicidal thoughts and aggressive and erratic behavior in patients who have taken Varenicline to quit smoking. The role of Varenicline in these cases is not clear because smoking cessation, with or without treatment, is associated with nicotine withdrawal symptoms and can also aggravate underlying emotional problems. However, not all patients described in the cases had preexisting emotional problems and not all had discontinued smoking.
For more information, please visit:
http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm106540.htm
FDA reviewing cases of suicidal ideation and occasional suicidal behavior
The FDA has notified healthcare professionals today about reports of suicidal thoughts and aggressive and erratic behavior in patients who have taken Varenicline to quit smoking. The role of Varenicline in these cases is not clear because smoking cessation, with or without treatment, is associated with nicotine withdrawal symptoms and can also aggravate underlying emotional problems. However, not all patients described in the cases had preexisting emotional problems and not all had discontinued smoking.
For more information, please visit: more information here
Visit the medication page for the following drugs:
Share your story! Tell us how MediGuard has helped you or someone you
love.
Download the MediGuard Mobile App to manage your prescription and
over-the-counter medications, for free.
Taking multiple medications puts you at risk for possible drug-drug
interactions
Monitor the medical treatment of you and your loved ones.
